DAWN
Day One Biopharmaceuticals Inc
NASDAQ: DAWN · HEALTHCARE · BIOTECHNOLOGY
$21.53
+0.00% today
Updated 2026-04-23
Market cap
$2.22B
P/E ratio
—
P/S ratio
14.06x
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$6 – $22
Volume
4.5M
Day One Biopharmaceuticals Inc (DAWN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |